Columbia Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-821	Closed	-$111K	–	221
2019 Q1	$111K	Buy	+821	New	+$102K	0.03%	210
2018 Q4	–	Sell	-995	Closed	-$138K	–	226
2018 Q3	$138K	Buy	+995	New	+$125K	0.04%	200
2017 Q1	–	Sell	-1,780	Closed	-$218K	–	217
2016 Q4	$218K	Hold	1,780	–	–	0.07%	165
2016 Q3	$218K	Hold	1,780	–	–	0.08%	169
2016 Q2	$208K	Sell	1,780 -750	-30%	-$106K	0.07%	163
2016 Q1	$352K	Hold	2,530	–	–	0.13%	132
2015 Q4	$482K	Hold	2,530	–	–	0.19%	107
2015 Q3	$396K	Hold	2,530	–	–	0.16%	124
2015 Q2	$457K	Sell	2,530 -400	-14%	-$69K	0.17%	121
2015 Q1	$508K	Hold	2,930	–	–	0.19%	123
2014 Q4	$542K	Hold	2,930	–	–	0.21%	116
2014 Q3	$486K	Sell	2,930 -500	-15%	-$82.1K	0.2%	111
2014 Q2	$536K	Hold	3,430	–	–	0.22%	108
2014 Q1	$522K	Sell	3,430 -300	-8%	-$47.7K	0.23%	100
2013 Q4	$496K	Buy	+3,730	New	+$448K	0.22%	103